The Role of Alcohol Use in Incident TB Infection and Active TB Disease Among Persons Living with HIV
饮酒在艾滋病毒感染者结核感染和活动性结核病中的作用
基本信息
- 批准号:10303986
- 负责人:
- 金额:$ 52.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-10 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS/HIV problemAdherenceAdultAfrica South of the SaharaAgeAlcohol consumptionAlcoholsBehavior TherapyBiological MarkersBody mass indexBostonCD4 Positive T LymphocytesCause of DeathCell CountCollaborationsCountryCrowdingCutaneous TuberculosisDiseaseEnrollmentExposure toFutureGenderGoalsHIVHIV/TBHeavy DrinkingHouseholdHypersensitivity skin testingImmunityIncidenceInternationalInterventionKnowledgeMeasurementMediator of activation proteinMorbidity - disease rateMycobacterium tuberculosisOdds RatioParticipantPathway interactionsPersonsPhasePoliciesPopulationPositioning AttributePreventive therapyProspective StudiesResearchRiskRisk EstimateRoleRussiaSamplingSmokingSocioeconomic StatusTest ResultTestingTimeTreatment outcomeTuberculin TestTuberculosisUgandaViralalcohol interventionalcohol measurementalcohol researchalcohol riskantiretroviral therapybasecigarette smokingcofactorcohortdrinkingenvironmental tobacco smokeenvironmental tobacco smoke exposurefollow-uphigh riskhigh risk drinkinghigh risk populationlow socioeconomic statusmortalityphosphatidylethanolpreventprogramsprospectivereduced alcohol usescale upscreeningtherapy adherencetuberculosis treatment
项目摘要
Tuberculosis (TB) is the leading cause of death among persons living with HIV (PLWH); TB disease rates for
PLWH engaging in heavy alcohol use are 2-3 times those of alcohol abstainers and TB treatment outcomes
are poorer. TB preventive therapy (TPT) reduces the risk of progression from latent TB infection (LTBI) to TB
disease, and is being scaled up for PLWH in many high HIV/TB incidence settings. However, TPT does not
prevent new or repeat TB infection after TPT has ended, therefore PLWH who engage in heavy alcohol use
may be at increased risk for acquiring new TB infection even after receiving TPT. There has been little
research examining the impact of alcohol use on acquiring new TB infection separately from progressing to
active TB disease; this limits our ability to understand the role of alcohol use on the separate phases of TB to
optimize intervention strategies most appropriate for each. We propose to examine the risk of acquiring TB
infection and of incident active TB disease among PLWH with heavy alcohol use after receipt of TPT in PLWH
in Uganda, a high HIV/TB country. Our goal is to inform interventions to reduce the risk for acquiring new TB
infection in this group, including behavioral interventions to reduce alcohol use, and TPT strategies, such as
repeat short-course TPT to prevent active TB disease. First, we propose to examine the acquisition of new TB
infection by level of alcohol use among a cohort of PLWH with prior negative tuberculin skin test (TST) results,
in a sample of PLWH enriched for heavy alcohol use (Aim 1). We will adjust for key confounders such as
cigarette smoking, second-hand smoke, socio-economic status, household crowding, gender, age, nadir CD4+
T cell count, and prior TPT receipt. We will also examine the mediators of alcohol use on risk of TB infection,
such as lack of HIV viral suppression, bar attendance, and low body mass index, to determine if existing
alcohol interventions should incorporate these as additional targets. To accomplish this aim, we will leverage a
large cohort of PLWH including 50% engaging in high-risk drinking, that we previously tested for LTBI from
2017 to 2020 who were TST negative. We will re-enroll 500 persons and conduct repeat TST and active TB
screening yearly, over 4 years, to determine the rate of acquiring new TB infection. We will also determine
whether PLWH who engage in heavy alcohol use and have LTBI are at increased risk of progressing to active
TB disease, despite receipt of TPT, compared to persons engaging in lower risk or no alcohol use (Aim 2). For
Aim 2, we will leverage our prior cohort of 990 PLWH with LTBI who received TPT, with over 5000 person-
years of follow-up and well-characterized alcohol use and TPT electronic adherence measurement. Both aims
will leverage cohorts uniquely suited for these analyses and use objective alcohol biomarkers. These studies
will provide unprecedented prospective evidence needed to effectively target alcohol reduction interventions
and inform TPT strategies—such as repeated short courses of TPT—to prevent new TB infection and reduce
the risk of progression to TB disease for a high-risk group of PLWH: those engaging in heavy alcohol use.
结核病是导致艾滋病毒感染者死亡的主要原因;结核病发病率
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JUDITH ALISSA HAHN其他文献
JUDITH ALISSA HAHN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JUDITH ALISSA HAHN', 18)}}的其他基金
Biomarkers for Alcohol/HIV Research (BAHR) Study
酒精/艾滋病毒研究生物标志物 (BAHR) 研究
- 批准号:
10615910 - 财政年份:2022
- 资助金额:
$ 52.29万 - 项目类别:
Biomarkers for Alcohol/HIV Research (BAHR) Study
酒精/艾滋病毒研究生物标志物 (BAHR) 研究
- 批准号:
10481535 - 财政年份:2022
- 资助金额:
$ 52.29万 - 项目类别:
The Role of Alcohol Use in Incident TB Infection and Active TB Disease Among Persons Living with HIV
饮酒在艾滋病毒感染者结核感染和活动性结核病中的作用
- 批准号:
10683770 - 财政年份:2021
- 资助金额:
$ 52.29万 - 项目类别:
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 1/2)
减少饮酒并提高艾滋病毒/结核病合并感染饮酒者对结核病预防治疗依从性的干预措施(DIPT 1/2)
- 批准号:
9767523 - 财政年份:2017
- 资助金额:
$ 52.29万 - 项目类别:
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 1/2)
减少饮酒并提高艾滋病毒/结核病合并感染饮酒者对结核病预防治疗依从性的干预措施(DIPT 1/2)
- 批准号:
10238903 - 财政年份:2017
- 资助金额:
$ 52.29万 - 项目类别:
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 1/2)
减少饮酒并提高艾滋病毒/结核病合并感染饮酒者对结核病预防治疗依从性的干预措施(DIPT 1/2)
- 批准号:
9408285 - 财政年份:2017
- 资助金额:
$ 52.29万 - 项目类别:
Mobile technology to extend clinic-based counseling for HIV+s in Uganda
移动技术在乌干达扩大艾滋病毒临床咨询
- 批准号:
9906836 - 财政年份:2017
- 资助金额:
$ 52.29万 - 项目类别:
Training in Research Program on Alcohol Use by Persons with or at Risk for HIV
关于艾滋病毒感染者或高危人群饮酒研究计划的培训
- 批准号:
8603091 - 财政年份:2013
- 资助金额:
$ 52.29万 - 项目类别:
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV
艾滋病毒高危人群饮酒研究项目培训
- 批准号:
9918815 - 财政年份:2013
- 资助金额:
$ 52.29万 - 项目类别:
Training in Research Program on Alcohol Use by Persons with or at Risk for HIV
关于艾滋病毒感染者或高危人群饮酒研究计划的培训
- 批准号:
8901861 - 财政年份:2013
- 资助金额:
$ 52.29万 - 项目类别:
相似海外基金
Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
- 批准号:
10568717 - 财政年份:2023
- 资助金额:
$ 52.29万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10419967 - 财政年份:2022
- 资助金额:
$ 52.29万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10592441 - 财政年份:2022
- 资助金额:
$ 52.29万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10369750 - 财政年份:2021
- 资助金额:
$ 52.29万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10633248 - 财政年份:2021
- 资助金额:
$ 52.29万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10487516 - 财政年份:2021
- 资助金额:
$ 52.29万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
10228564 - 财政年份:2018
- 资助金额:
$ 52.29万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
9347041 - 财政年份:2017
- 资助金额:
$ 52.29万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9480702 - 财政年份:2016
- 资助金额:
$ 52.29万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9906853 - 财政年份:2016
- 资助金额:
$ 52.29万 - 项目类别:














{{item.name}}会员




